Related Experiment Video
Updated: Mar 26, 2026
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
Prostate Cancer: PI-RADS Version 2 Helps Preoperatively Predict Clinically Significant Cancers
Sung Yoon Park1, Dae Chul Jung1, Young Taik Oh1
1From the Department of Radiology and Research Institute of Radiological Science (S.Y.P., D.C.J., Y.T.O.), Department of Pathology (N.H.C.), Department of Urology (Y.D.C., K.H.R., S.J.H.), and Avison Biomedical Research Center (K.H.), Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of Korea.
Prostate Imaging Reporting and Data System (PI-RADS) version 2 effectively aids in detecting clinically significant prostate cancer. This magnetic resonance imaging tool demonstrated strong predictive value in a study of 425 patients undergoing radical prostatectomy.
Area of Science:
- Radiology
- Oncology
- Urology
Background:
- Accurate preoperative detection of clinically significant prostate cancer is crucial for treatment planning.
- Magnetic resonance (MR) imaging has become integral in prostate cancer assessment.
- The Prostate Imaging Reporting and Data System (PI-RADS) provides a standardized method for reporting MR findings.
Purpose of the Study:
- To evaluate the efficacy of PI-RADS version 2 in identifying clinically significant prostate cancer.
- To determine if PI-RADS scoring is a significant independent predictor of clinically significant disease.
Main Methods:
- Retrospective analysis of 425 patients with prostate cancer who underwent MR imaging and radical prostatectomy.
- Preoperative parameters including PI-RADS version 2 scores were analyzed.
- Clinically significant prostate cancer defined by Gleason score, tumor volume, or extracapsular extension.
Main Results:
- Multivariate analysis identified PI-RADS score as the sole significant preoperative predictor of clinically significant prostate cancer for both readers.
- PI-RADS scores showed excellent interreader agreement (weighted κ = 0.801).
- All investigated preoperative parameters were significant in univariate analysis.
Conclusions:
- PI-RADS version 2 is a valuable tool for the preoperative diagnosis of clinically significant prostate cancer.
- The standardized reporting system enhances diagnostic accuracy and interreader reliability.
- Utilizing PI-RADS can potentially improve surgical planning and patient outcomes.
